ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Stem Cell Research Breakthrough: How Scientists Plan to One Day Soon Treat … – University Herald

Stem Cell Research Breakthrough: How Scientists Plan to One Day Soon Treat …University HeraldAccording to NBC News, a new study was successful in cloning the stem cells of a woman with Type-1 diabetes. The cells were a match to her and the disease, marking a potential breakthrough to how Type-1 diabetes, a disease that affects … Continue reading

2014-04-29 Michael Zand NEWS

Analysis Attacks Stem-Cell Data in CHD, Another Gives Tepid Support – Medscape

Analysis Attacks Stem–Cell Data in CHD, Another Gives Tepid SupportMedscapeLONDON, UK — The promise of autologous stem–cell therapy for ischemic heart disease has either taken an existential hit, if one agrees with an analysis in this week’s literature, or deserves subdued, provisional approval if one favors another. The … …read more   &nbs… Continue reading

2014-04-29 Michael Zand NEWS

Stem Cell Powder Regrows Man’s Finger–Story Is Viral but Is It Real? – Guardian Liberty Voice

Guardian Liberty VoiceThe stem cell powder and sheets will soon be undergoing several types of clinical trials. In the first trial, a woman suffering from esophageal cancer will have the stem cells placed in her esophagus after surgery to see if the tissues there will … …read more   &nbs… Continue reading

2014-04-29 Michael Zand NEWS

Stem Cell Cloning May be Aid Treatment for Diabetes – The Charlottesville Newsplex

Stem Cell Cloning May be Aid Treatment for DiabetesThe Charlottesville NewsplexThe new work is a step toward providing genetically matched replacement cells for transplant, said Dieter Egli of the New York Stem Cell Foundation Research Institute in New York. He led the research, which was reported online Monday in the journal … …read more   &nbs… Continue reading

2014-04-29 Michael Zand NEWS

Stem cell breakthrough: patient-specific therapies for type 1 diabetes – Medical News Today

Stem cell breakthrough: patient-specific therapies for type 1 diabetesMedical News TodayA team of scientists from the New York Stem Cell Foundation Research Institute and Columbia University Medical Center, also in New York, claim to have created the first disease-specific embryonic stem cell line with two sets of chromosomes. The … …read more   &nbs… Continue reading

2014-04-29 Michael Zand NEWS

Doubts over heart stem-cell therapy – Nature.com

Doubts over heart stem–cell therapyNature.comEarly-phase clinical trials have reported that adult stem cells are effective in treating heart attack and heart failure, and many companies are moving quickly to tap into this potentially lucrative market. But a comprehensive study that looked at … …read more   &nbs… Continue reading

2014-04-29 Michael Zand NEWS

Researchers Create Personalized, Disease-Specific Stem Cells – RedOrbit

RedOrbitResearchers reported on Monday the creation of the first disease-specific line of embryonic stem cells made with a patient’s own DNA, a major breakthrough in field of regenerative medicine. The achievement marks the first time cloning technologies have … …read more   &nbs… Continue reading

2014-04-29 Michael Zand NEWS

Stem Cell Breakthroughs Renew Old Cloning Fears – Genetic Engineering News

Genetic Engineering NewsFour studies published in recent weeks are giving researchers new hope that key hurdles hobbling stem cell research can finally be overcome—while renewing fears that the reported advances will lead to reproductive cloning. Researchers on Monday … …read more   &nbs… Continue reading

2014-04-29 Michael Zand NEWS
  • 1
  • …
  • 3,157
  • 3,158
  • 3,159
  • 3,160
  • 3,161
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.